Follow

Recently wrote for this postmortem of the Oxford/AZ mucosal Covid vaccine trial. The intranasal spray version of ChAdOx1 failed to induce strong antibody responses.

But the column also includes a bit on the positive outcome of CanSino's trial using an inhaler (approved as a booster for 2x Coronavac).

nature.com/articles/d41591-022

Sign in to participate in the conversation
Qoto Mastodon

QOTO: Question Others to Teach Ourselves
An inclusive, Academic Freedom, instance
All cultures welcome.
Hate speech and harassment strictly forbidden.